Lipase-stable thickening agent
View Patent ↗The invention relates to novel compounds, to aqueous, in particular surfactant-containing formulations containing the novel compounds and to the use of the novel compounds as thickening agents of aqueous, in particular surfactant-containing formulations.
1. An aqueous formulation comprising a compound of formula (I)
wherein R 1 and R 2 of the compound of formula (I) are selected from one of the following groupings
R 1 ═H or 2-hydroxypropyl and R 2 =2-hydroxypropyl;
R 1 ═H or 2-aminoethyl and R 2 =2-aminoethyl;
R 1 ═H or N-(2-hydroxyethyl)aminoethyl and R 2 ═N-(2-hydroxyethyl)aminoethyl;
R 1 ═H or 2-(2-hydroxyethoxy)ethyl and R 2 =2-(2-hydroxyethoxy)ethyl;
R 1 =methyl or 2,3,4,5,6-pentahydroxyhexyl and R 2 =2,3,4,5,6-pentahydroxyhexyl; and
R 1 ═H or 2-(1-piperazinyl)ethyl and R 2 =2-(1-piperazinyl)ethyl.
2. The aqueous formulation of claim 1 , wherein R 1 ═H and R 2 ═N-(2-hydroxyethyl)aminoethyl.
3. The aqueous formulation according to claim 1 , wherein said aqueous formulation further comprises at least one surfactant.
4. The aqueous formulation according to claim 3 , wherein the at least one surfactant is a mixture of at least one anionic surfactant and at least one nonionic surfactant.
5. The aqueous formulation according to claim 3 , wherein the at least one surfactant is a biosurfactant selected from rhamnolipids, sophorolipids, trehalose- and other mycolic-acid-containing glycolipids, and also cellobiose and mannosylerythritol lipids.
6. The aqueous formulation according to claim 1 , wherein said aqueous formulation further comprises at least one enzyme.
7. The aqueous formulation according to claim 1 , wherein said at least one compound of formula (I) is present in an amount of from 0.1% by weight to 50% by weight, where the % by weight refers to the total formulation.